Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 12, Number 1—January 2006

Coordinated Response to SARS, Vancouver, Canada

Danuta M. Skowronski*Comments to Author , Martin Petric*, Patricia Daly†, Robert A. Parker‡, Elizabeth Bryce†, Patrick W. Doyle†, Michael A. Noble†, Diane L. Roscoe†, Joan Tomblin§, Tung C. Yang¶, Mel Krajden*, David M. Patrick*, Babak Pourbohloul*, Swee Han Goh*, William R. Bowie#, Tim F. Booth**, S. Aleina Tweed*, Thomas L. Perry†, Allison McGeer††, and Robert C. Brunham*
Author affiliations: *British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada; †Vancouver Coastal Health, Vancouver, British Columbia, Canada; ‡Fraser Health, New Westminster, British Columbia, Canada; §Royal Columbian Hospital, New Westminster, British Columbia, Canada; ¶St. Paul's Hospital, Vancouver, British Columbia, Canada; #University of British Columbia, Vancouver, British Columbia, Canada; **National Microbiology Laboratory, Winnipeg, Manitoba, Canada; ††Mount Sinai Hospital, Toronto, Ontario, Canada

Main Article

Table 1

SARS CoV antibody titers by microneutralization assay in persons with laboratory-confirmed SARS in VCMA*

Serum sample no. Patient 0
Patient 1
Patient 2
Patient 3
Patient 4
Days after onset Titer Days after onset Titer Days after onset Titer Days after onset Titer Days after onset Titer
1 10 1:32 16 1:128 4 <1:8 3 <1:8 11 <1:8
2 19 1:128 29 1:32 14 1:32 36 1:128 28 1:32
3 45 1:32 637 1:64 20 1:128 224 1:128 203 1:128
4         217 1:128 466 1:64 463 1:64
5         481 1:64        

*By number of days after symptom onset that serum was collected. SARS, severe acute respiratory syndrome; CoV, coronavirus; VCMA, Vancouver census metropolitan area.

Main Article

Page created: February 21, 2012
Page updated: February 21, 2012
Page reviewed: February 21, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.